Naturelle Consumer Products Ltd have been granted authorisation by the UK Medicines and Healthcare Products Agency (MHRA) to manufacture aseptically filled sterile sachets for use in human investigational medicinal products for phase 1, 2 and 3 clinical trials.
This authorisation comes after five years extensive research and development in the process by the company. Naturelle are the first company in the world to offer customers aseptically sterile single dose unit measures in a sachet.
This development creates market opportunity for Pharmaceutical and Medical companies that have products with ingredients sensitive to heat and radiation, the standard industry methods used for product sterilisation. With aseptic processing at cool or ambient temperatures Naturelle can process sterile products without compromise to product integrity.